LOTTE Biologics Wins "Best New or Relaunched CDMO" at 2026 Awards

[Han Kwangbeom, Edaily Reporter] LOTTE Biologics (Co-CEOs James Park and Shin Yooyeol) announced today that it received a prestigious honor at the 2026 CDMO Leadership Awards, a premier recognition in the global contract development and manufacturing organization (CDMO) industry.

Shin Yooyeol (fifth from left) and James Park (sixth from left), Co-CEOs of LOTTE Biologics, pose for a commemorative photo with employees after winning the 'Best New or Relaunched CDMO' award at the 2026 CDMO Leadership Awards.

(Photo: LOTTE Biologics) The CDMO Leadership Awards, hosted by "Outsourced Pharma" and "Life Science Connect," recognize CDMOs that have demonstrated outstanding performance over the past 24 months.